Neurogenetics - Boards

0.0(0)
Studied by 2 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/95

encourage image

There's no tags or description

Looks like no tags are added yet.

96 Terms

1
New cards

Holoprosencephaly


Incomplete division of embryonic forebrain (prosencephalon) into lateral hemispheres

  • - 1:250 conceptions/1:10,00 live births —> one of the most common embryonic abnormalities, but most are lethal in utero

  • - Assoacted with dysmoprphic features related to laterality: cylopia, probisoicus, hypertelorism, SCMI (a tooth thing?)

  • “Face preditcs the brain” : mental retardaiton, seixures, pituitary insufficney, FTT


2
New cards

Holoprosencephaly Eitology

- 90% genetic

  • Half are Chrsome Abnormalities: OVERWHELMINGLY Trisomy 13 (Patau)

  • Half are Monogenic disorders: Mutations in SHH (Non-syndromic) autosomal domaint


3
New cards

HPE and Patau syndrome

***MOST COMMON CAUSE OF HPE ACROSS ALL GENETIC CAUSES***

  • HPE occurs with:

    • Facial clefting

    • ****POLYDACTYLY***

    • CHD

    • PKD

    • Omphalocele

  • Severe mental retardation

  • 3% Survival at 1 Year

  • Recurrence risk: 1%


4
New cards

HPE and SMith-Lemli-Opitiz Syndrome

HPE with:

  • Cleft palate

  • CHD,

  • GU anomaly (usually men with genital ambiguity)

  • low set ears

  • ****2-3 Toe Syndactyly*****


  • Variable intellectual disability, grow retardation and life span

Etiology: 7-Dehydrocholestrol Reductase (7-DHCR) Gene Mutation

Recurrence Risk: 25% (Autosomal Recessive)

5
New cards

HPE and Sonic Hedhog (SHH) Pathway gene mutation

HPE is isolated and with variable mental retardation

Etiology: SHH gene mutation

Recurrence risk: 50% for affected Indvidual (Autosomal Dominant)

→***minimal recurrence risk if parent unaffected, but variable expressivity so test parents***

6
New cards

HPE and Genetic Testing

We can suspect from ultra sound but need empiric testing

  • Karyotype: for Trisomy 13

  • CMA: for pathogenic CNVs

  • Gene Testing:

    • SHH (Sonic hedgehog) if ISOLATED

      • Parents need testing as well: variable expressivity in a SHH mutation carrier

    • Smith-Lemi-Optiz and/or other conditions if SYNDROMIC


7
New cards

HPE Outcomes

  • There will ALWAYs be some degree of mental retardation: but can be VERY variable

  • If there is a Cyclopia/probiscis: Always Lethal

  • If Trisomy 13: 5-8% survival 12months



8
New cards

Lissencephaly

  • The absence or significant reduction of the normal folds and grooves (gyri and sulci) on the surface of the brain:

    • “Smooth Brain” with lower surface area for cortical neurons

    • a “inside out” cortex (layers on the outside are stuck on the inside)

    • Can be “diffuse”(entire brain) or “patchy” (cobblestone)

  • Found via MRI either:

    • Prenatal: can by viewed at >24 weeks gestation - at this point devleoping brains gain the ‘gyration’

    • At birth

  • Invariable will cause some degree of Intellectual Disability

  • Important Associated syndromes:

    • Miller-Dieker Syndrome

    • Muscle-Eye-Brain Disease


9
New cards

Miller-Dieker Syndrome

****#1 Cause of Lissencephaly****

  • Microdeletion syndrome in 17p13.3: ~ 50 genes in region

    • Lis1→ Lissencephaly

    • YWHAE→ greater intellectual severity

    • Other genes→ Dysmorphic features (

      • Midline vertical forehead crease/furrowing

      • Facial: depressed nasal bride, micrognathia

      • Cardiac/GI Anomalies

Essentially Always De Novo (not inherited): low reproductive fitness due to severe MR

Prognosis:

  • severe growth and Mental retardation,

  • life expectancy <2 years


10
New cards

Muscle-Eye-Brain Diseases

  • A common cause of lissencephaly (Brain) that are a part of syndromic features that include ophthalmalgia abnormalities (Eye) and progressive muscular dystrophy (Muscle)


3 Types from most to least severe

  • *POMT1 Gene (Walker-Warburg)*

  • Fukutin Gene (Fujuyama CMD)

  • POMGT1 Gene (Finnish MEB disease

All have varying degrees of

  • Progressive muscular dystrophy (muscle disease): High Creatine Kinase with a progressive muscle weakness

  • Micorpathalmia: small eye (Eye disease)

  • Cobblestone Lissencephaly (Brain disease)

Prognosis: Blindness and progressive weakness that leads to death (usually from resipatory failure)

Inheritance: All Autosomal Recessive




11
New cards

Walker-Warburg Syndrome

  • One of the 3 Muscle-Eye-Brain Diseases that are associated with Lissencephaly → of the 3 LESS severe (but its still bad)

Features

  • Brain: COBBLESTONE Lissencephaly

  • Eye: Microphthalmia (small eye) and other ophthalmologic abnormities - Retinal malformation

  • Muscle: Congenital Muscular Dystrophy → increased CK


Prognosis: very poor → death in infancy or early childhood


12
New cards

Hydrocephalus

  • Increase in Cerebral Spinal fluid in the cranium

  • Incidence 1:500 → Fairly common

  • Mostly NON-GENETIC causes (blockages in ‘flow’): potentially normal IQ if treated, low recurrence risk

  • But, there still are genetic causes: most important it

    • L1-CAM Hydrocephalus or “X-Linked Recessive Hydrocephalus”



13
New cards

L1CAM Congenital Hydrocephalus

  • Hydrocephalus that is cause by a single gene mutation in the L1CAM gene that is on the X-chromosome

Features : MALES ONLY

  • Hydrocephalus WITH stenosis of Aqueduct of Sylvius( exit for CFS from the ventricular system)

    • ***Intellectual disability despite treatment***

  • Spasticity of the muscles

  • Adducted thumbs: thumb cannot be straightened

Need to check in L1CAM gene in mom if:

  • History of unexplained son hydrocephalus

  • A Son with a adducted thumbs


14
New cards

Dandy-Walker Malformation

  • a specific developmental malformation of the posterior fossa (back of the brain)

    • Hypoplasia of the cerebellar vermis

    • Cystic dilatation of the fourth ventricle

    • Enlargement of the posterior fossa

  • Causes

    • Cerebellar dysfunction: Ataxia, Nystagmus

    • Seizures, Apnea, Hypotonia

    • Increased risk for Mental Retardation but normal IQ possible (>50%)


15
New cards

Meckel Gruber syndrome


  • Genes :MKS1 – TMEM67 – CEP290 – CC2D2A – RPGRIP1L

    • OVERLAP WITH JOUBERT SYNDROME

    • Ciliopathy

Inheritance

  • Autosomal Recessive

Clinical Features

Lethal

Classic triad of

  • Brain malformation:

    • ***Occipital Encephalocele***(hole in skull)

    • Dandy-Walker Malformation (both posterior fossa abnormalities)

  • Bilateral Cystic Kidneys → Potters Sequence

  • Postaxial Polydactyl

Differential Diagnosis:

  • Joubert Syndrome: both ciliopathies

  • Bardet-Biedl Syndrome: polydactyl and renal disease shared

  • Trisomy 13: polydactyl, CNS anomalies, cystic kidneys shared

Testing:

  • CMA - excluded chromsal disorders

  • Multigene ciliopathy panel

  • prenatal exome if CMA is nromal depsite utlrasound findings


16
New cards

Hydranencephaly

During devleopment, when brain structures do not get proper vascualrazation, they will not delvope and simply liquify: this iswhat happens (holy shit)

Clinical: prentatl liquication necrosis of coritcal sturcutres (instead of a brain/coritcal strucutres there is just fluid)

Etiology: pirmality vascualr disrution (never a fetal gene error)

Recurrence Risk: Very Low- tends not to be genetic, but RARE cases of Autosomal Recessive families

17
New cards

Joubert Syndrome


A typcially NON-Lethal (unlike Meckel-Gruber) ciliopathy that affects brain, kidney, and liver

  • Brain (DISTINCT):

    • ***Molar Tooth Sign: pocket in the midline posterior brain → very distinct MRI sign***

    • Mental retardation, hypotonia, seizures, ataxia, nystagmus (irregular eye movements), ABNROMAL BREAHTING

  • Kidney/Liver:

    • Hepatic fibrosis

    • Nephronophthisis

  • Dysmorphic Facial Features

    • tall forehead, upturned nose, open mouth

Etiology: Recessive and X-Linked


18
New cards

A 32yo G1P) Femal with gestational diabetes has a level II fetal ultrasound at 22 weeks gestion which shows ventricular enlargement.

Which is the possible diagnosis?

Hydranencephaly

Hydrocephaly

Holoprosencephaly

Lissencephaly

Any of the above

Any of the above

19
New cards

A 32yo G1P) Femal with gestational diabetes has a level II fetal ultrasound at 22 weeks gestion which shows ventricular enlargement. AND

She reports no medication or drug use asiade from prenatal vitamins, there is no family history of hydrocephalus and she had a normal ‘triple screen’.

Fetal Skull, XRAY, Head CTScan, Brain MRI, AMinocetisis or Chrsome Microarray?

Fetal Brain MRI

20
New cards

A 32yo G1P) Femal with gestational diabetes has a level II fetal ultrasound at 22 weeks gestion which shows ventricular enlargement. AND

She reports no medication or drug use asiade from prenatal vitamins, there is no family history of hydrocephalus and she had a normal ‘triple screen’.

On tkaing a family history the mother has leanring diablties and didn;t graduate high school. When she smiles you notice she has one centeral maxillary incisor.

This suggest her recurrence risk in the futre pregencies is closest to:

0%

1%

25%

up to 50%

100%


Up to 50%: since she has (ID + Incisor) suggest a mild form of HPE, which does not indicate syndromic HPE. So, she probably has the form from SHH pathway mutations ,which are Autosomal Dominant —> thus, 50% recurrence to have another child with HPE

21
New cards

Developmental Disalbites

Structurally normal brain (no Malformation), but does not function as normal

CNS disfunction

  • Developmental delays

  • Intellectual disability

  • Autism

  • Stuttering

  • Hearing/Visual impairment

  • ADD/ADHD

  • Cerebral Palsy

  • Seizures


22
New cards

Autism Spectrum Disorder

  • reorganization of multiple disorders under one

    Criteria

  • Deficits in social communication and social interaction

  • Restricted, repetitive patterns of behavior, interests or activities

  • Onset of symptoms in infancy/early childhood

  • symptoms limit and impair everyday functioning


23
New cards

Autism Screening: Excluding contributing Conditions

  • Lead Intoxication → Check Lead Levels in blood/CSF

  • Hypothyroidism → Check TSH levels

  • Deafness/Hearing loss → Audiology Evaluation

  • Extreme impovershed Environment

  • Prenatal Exposures → Toxins, Infections, Premature, Brain trauma


24
New cards

Autism Incidence

Male: Female Raito of 4:1 → MORE MEN THAN WOMEN

Autism Heritability:

  • Familial Autism recurrence rate:

    • 5-10% if 1 child affected

    • 25% if 2 Children affected

  • Heritability Factor (Genetic Cause): 37-90%


25
New cards

Heterogenous Genetic Autism Associated Syndromed

Can be single gene, Mendelian or Chromosomal

Single gene

  • Fragile X (#1 cause)

  • Rett Syndrome

  • Tuberous Scerlrosis

  • Neurofibromatosis Type !

  • PTEN Syndrome

  • Smith-Lemli-Optiz

  • Kallman Syndrome

  • Soto syndrome

  • IEM → PKU

Chromsomal

  • Down Syndrome

  • Klnifleter

Microdeltion

  • Prader willi

  • Angelman

  • Smith-Magenis

  • Digeorge

  • Williams


26
New cards

Common single Gene Autism-related Disorder

  • Fragile X (FMR1 gene, XL): 2%

  • Ret Syndrome (MECP2 Gene, XLD): 1%

  • PTEN Related (PTEN gene, AD): 1% (15% if macrocephaly)

  • Tuberous Sclerosis (TSC1-4 gene, AD): 1% (5-15% if epilepsy)

  • Neurofibromatosis Type 1 (NF1 gene, AD): 1%


27
New cards

Fragile X Syndrome: Overview

#1 Genetic Cause of Moderate MALE Mental Retardation

  • Caused by CGG repeats on the FMR1 gene located on the X-chromosome

  • CGG repeats “expand” during female meiosis → increased of repeats in the EGGS

  • 1:3,600 Males

  • Premutation carriers: 1:260 female and 1:800 males



28
New cards

Fragile X: Complex Screening

29
New cards

Fragile X Syndrome: Features

  • Typical Dysmorphgoly

    • Long face

    • Prominent ears

    • **Macrocephaly**

    • High forehead

    • Macroorchidism

  • Mental Retardation

    • Males: 90% severe, 10% Borderline MR IQ

    • Female: 50% normal IQ, 25% borderline MR, 25% Severe

  • Behavior

    • 80% Autism

    • >90% ADHD

  • Seizures: 25-40%

  • Developmental Dealy



30
New cards

Fragile X: Premutation Carriers

Premutation carriers are at risk of

  • Fragile X-associated Tremor/Ataxia Syndrome (FXTAS) : Parkinson-like condition,

    • 33% of male carriers,

    • 6% of female carriers;

    • age of onset after 50yo

  • Primary Ovarian Insufficiency (FXPOI):

    • 25% of premutation carriers,

    • early menopause by age of 40yo


31
New cards

Fragile X: Repeats

Higher risk for expansion if inherited from MOM rather than DAD

“CGG” Trinucleotide repeats in FMR1

  • 6-40 repeats: Normal gene expression

  • 45-54 repeats: “Grey Zone” unaffected parent can have expansion into premutation range (not full mutation range)

  • 60-200 repeats: Premutation; can expand, increased FMR1 expression

  • >200 repeats: Full mutation, No FMR1 expression


32
New cards

Fragile X: Interruptions

“AGG” Interruptions: can lower the chance for expansion

  • More AGG interruptions= Decreased expansion risk

  • MOST IMPACTFUL for “Grey zone” Women → testing women for AGG interruptions as well as CGG repeats can refine risk estimate


33
New cards

Aicardi Syndrome

Gene: CAUSE UNKNWON

  • ONLY OCCURS IN 46,XX Female

Inheritance

  • ***X-LINKED RECESSIVE****

    • COMPLETLE DE NOVO

Clinical Features

CNS

  • *****Agensis of the Corpus Callosum***** (hallmark)

  • ***SEIZURES*** (first few months of life)

    • INFANTILE SPASS

Eye

  • ****Chorioretinal Lacunae****(absent retinal pigment epithelium)


34
New cards

Rett Syndrome

MECP2 mutation - important for methylation control

X Linked Dominant: Female Only (Lethal in all XY Males) → ALWAYS DE NOVO (never family hx of Rett)


Typical Signs and Symptoms

  • Normal Development 6-18 months

  • Regression 1-4yo

    • Acquired Microcephaly: head growth slows but body keeps growing

    • Mental Retardation,

    • ***Seizures***,

    • Ataxia,

    • Repetitive Hand movement,

    • Apnea

  • Stabilization Period 2-10yo

    • slight increased awareness + minimal verbal communication

  • Later Motor Deterioration after 10yo

    • Loss of mobility, full physical disability → Early Death


35
New cards

PTEN Mutations

***Autism with Macrocephaly***

Autosomal Dominant mutations in PTEN Gene → 17% of Macrocephalic Autistic Children have PTEN mutation

PTEN mutations overlap with Cancer Syndromes:

  • Cowden Syndrome:

    • Increased Breast, Thyroid, Kidney, Colorectal, Endormtial Cancer

    • Palmoplantar Keratosis

    • Trichilemmomas

    • Oral Fibroams

  • Bannayan-Riley-Ruvalcaba syndrome:

    • Mental Retardation

    • Hamartomas GI polyps

    • Penil Lentrigines (spots on end of pen island)

***ALL PATIENTS WITH AUTISM AND MACROCEPHALY SHOULD GET TESTED INTHE PTEN GENE***



36
New cards

Tuberous Sclerosis: Overview

****20-50% Have Autism****

  • Autosomal Dominant TS Gene Mutation (4 Genes)

    • 75% De Novo

    • 25% Inherited

    • TS gene sequencing detects most mutations

  • Classic Clinical Triad

    • Adenoma Sebaceum (50-80%)

    • Epilepsy (75%)

    • Mental Retardation (50%)



37
New cards

Tuberous Sclerosis: Major Diagnostic Features

Need >1 feature to make a diagnosis (different from the common clinical triad → non-specific features (epilepsy, MR, Autism, etc.)

  • Heart

    • ****Congenital Rhabdomyoma****

  • Skin:

    • “Ash-Leaf” Macules (>3)

    • Facial Angiofibroma

    • Periungual Fibroma

  • Eye

    • Retinal nodular hamartomas

  • Lung

    • Lymphangiomyomatosis

  • Kidney:

    • Renal angiomyolipoma


38
New cards

Neurofibromatosis Type 1 (NF1): Overview

***Learning Disability in ~50% (ADHD, AUTISM)***

  • NORMAL INTELLGENCE

  • Not increased risk for seziures

Autosomal Dominant Neurofibromin Gene Mutation:

  • 50% De Novo

  • 50% Inherited

  • NF1 Gene sequencing detects most cases




39
New cards

Neurofibromatosis Type 1 (NF1): Features + Diagnostic criteria

Major Diagnostic Features (Need >1)

  • ***6 or more Cafe-Au-Lait Sports***

  • 2 or more Neurofibromas

  • 2 or more Lisch nodules (Iris Hamartomas → contrast with TS Retina Hamartomas)

  • Optic Glioma

  • Axillary or Inguinal Freckling

  • Osseous Lesions

  • 1st Degree Relative Diagnosed with NF1

Major Morbidities

  • Large Neurofibroma mass → become malignant

  • Increased Cancer: Pheochromocytoma

  • Resistant Hypertension → Renal Artery Stenosis

  • Learning Disabilities (AUTISM) but NORMAL IQ


40
New cards

Mowat-Wilson Syndrome: overview

ZEB2 Mutation: Important for neural crest migration

Inheritance

  • ZEB2 gene mutation: Autosomal Dominant

  • ALWAYS DE NOVO

Clinical Features

  • ***Hirschsprung Disease***

  • Seizures

  • Intellectual Disability

    • Minimal speech

    • *HAPPY DEMANOR*

    • *FREQUENT LAUGHTER*

    • *WIDE-BASED GAIT*

      • (Often confused with ANGELMAN SYNDROME)

  • Dysmorphic Facial Features

    • hypertelorism (eye too close)

    • Broad Flared eyebrows

    • Low columella

    • Prominent, pointed chin

    • ***Uplifted earlobes***

  • Congenital heart defects

  • Microcephaly

Treatment: Multidisciplinary

  • Neuro, Developmental Pediatric, Ophthalmologist, GI, Cadio, PT/OT/ST


HALLMARK: Hirschsprung disease + a characteristic facial appearance (Earlobes or Chin) + severe developmental delay




41
New cards

Rubenstien-Taybi Syndrome

CREBBP mutation: histone activity during embryonic development

Inheritance

  • Autosomal Dominant

  • ALWAY DE NOVO

Clinical Features

  • ****BROAD THUMBS AND GREAT TOES*****

  • Dysmorphic Facial Features

    • grimacing smile

    • down slanting palpebral fissures

    • highly arched eyebrows

    • long eyelashes

    • prominent or beaked nose

  • Developmental/Intellectual Delay: wide variability

    • Intellectual disability: wide variability - mild-moderate range

    • Autism (40%)

  • Birth Defects

    • Heart

    • GU

    • Dysplastic Corpus Callosum

  • Eye and Ear → issues with hearing and sight

Treatment: Multidisciplinary

  • Neurology, Development pediatrics, Ophthalmology, Audiology, GI, Cardio, PT/OT/ST


Hallmark: Broad thumbs/great toes + Intellectual Disability


42
New cards

Cornelia de Lange syndrome

Genes: NIPL (60%), RAD21, SMC3, BRD4 mutation (+ HDAC8 and SMC1A)

Inheritance:

  • Autosomal Dominant (usually)

  • X-linked for HDAC8 + SMC1A

  • Mostly De Novo (1% Inherited)

Clinical Features: Wide spectrum - mild cases vs severe are STARK contrast

  • Dysmorphic Facial Features

    • ****Connected Eyebrows (Synophyrs)****

    • ***Long eyelashes***

    • short upturned nose

    • micrognathia

    • thin upper lip

  • Severe Fetal Growth Restriction

  • **Upper Limb Reduction Abnormalities (mild to severe) **

    • Small hands, short fingers (mild)

    • ****Absent Finger, Hand, or Forearm****

  • Intellectual Disability (moderate to severe)

  • Autism*****

  • Congenital Heart Defects

  • Hearing Loss


Hallmark: [Synophrys] + [limb defects] + [growth restriction]



43
New cards

Kabuki Syndrome

Genes: KMT2D (70%) and KDM6A (8%)

Inheritance

  • Autosomal Dominant → KMT2D

  • X-Linked → KDM6A

  • ALWAYS DE NOVO

Clinical Features

  • Dysmorphic Facial Features

    • ***Long Palpebral Fissures***

    • *Eversion of lower eyelid*

    • Arched, broad Eyebrows

    • Large prominent ears

  • ****Persistent Fetal Fingertip Pads****

  • Congenital Heart Disease

    • **Coarctation of the Aorta**

  • Hypotonia + Developmental Delay → Post-Natal Growth Deficiency

  • Intellectual Disability


Hallmark: Fetal Fingertip Pads + Palpebral Fissures + CHD + Hypotonia/Post-natal growth deficiency

"Kabuki actors have dramatic EYES and wear FINGER PADS."


44
New cards

Developmental Epileptic Encephalopathies

Etiology:

  • 50% genetic cause Whole Exome/Genome sequencing recommended (huge gene heterogeneity, >900 genes associated)

  • Most common gene SCN1a Mutation associated Dravet Syndrome

  • Prevalence 1:600-1,000

Clinical Features

  • Seizures, slowed development and regression, onset infancy or childhood

  • overlap with many different epileptic syndromic presentations


45
New cards

Dravet Syndrome

Gene: SCN1A (neuron ion channel protein → regulates activity, LOF = overexcitement)

Inheritance

  • Autosomal Dominant

  • ALWAYS DE NOVO

Clinical Features

  • Normal birth and initial development

  • Infancy (6-12months): Development of PROLONGED FEBRILE SEIZURES

    • Triggered by Fever, Vaccine (immune response), Hot Baths → high heat

  • Childhood:

    • Intellectual disability

    • Ataxia

    • Hypotonia

  • Lifelong:

    • Epilepsy

    • Intellectual disability

    • Gait abnormalities

    • Increased risk of Sudden Unexpected Death in Epilspey (SUDEP)

Treatment/Management

  • Neurologist/Epileptologist: molecularly guided anti-epileptic therapy

  • Avoid sodium channel blockers


[Dravet = Dramatic Fever Seizures]


46
New cards

Chromosomal Autism Associated Disorder

  • Down Syndrome (Trisomy 21)

  • Klinefelter Syndrome (47, XXY)

  • Non-Eponymous Microscopically visible chromosomal Del/Dup/Rearrangements in Individuals

  • All of these will be apart of workup for suspected Autism Desanges

    • Recommend chromosome analysis be offered to all individuals with unexplained autistic features

    • Overall incidence of detectable Microscopic Chromo. abnormalities: 2-4%


47
New cards

Microdeltion Autism Assoacted Syndromes

  • DiGeorge Syndrome (22q11.2 Deletion)

    • “CATCH22” :

      • Cardiac defects (interrupted aortic arch/TOF),

      • Abnormal facies (boxy nasal tip),

      • T-Cell immunodeficiency,

      • Clefting of lip/palate,

      • Hypocalcemia

  • Williams syndrome (7q11.23 Deletion):cocktail party

  • Prader-Wili Syndrome (Paternal 15q11-13 deletion/imprinting): Hungry

  • Angelman Syndrome (Maternal 15q11-13 deletion/imprinting): happy puppet

  • Smith-Magenis syndrome (17q11.2 Microdeletion): stuff in ass+ Self injusry disorder


48
New cards

Genetic Evaluation of Autism

  • Look for Underlying Etiology: Asses for the hallmarks syndromes

    • Physical exam: including

      • morphologic Skin Exam (Wood Lamp),

      • Facial features

    • RULE OUT other non- genetic casues:

      • Audiology

      • Lead and thyroid testing in all,

      • MRI/EEG as indicated

  • Based on what you find: Syndrome Specific Genetic Testing if Indicated

    • PTEN gene testing if macrocephalic,

    • TS or NF1 testing if neurocutaneous signs

  • Empiric Genetic Testing if Cause is Unclear

    • Chromosome microarray analysis and karyotype for all

    • Fragile X DNA testing for all males and females

    • Rett syndrome MECP2 gene testing for all females only

Newer ASD Gene Testing

  • Autism/ID gene panels

  • Whole Exome/Whole Genome Sequencing (WES/WGS)


Testing Yield: 20-30% will have a GENETIC EXPLINATION


49
New cards

Coffin-Lowry Syndrome

Gene: RPS6KA3

Inheritance

  • X-Linked DOMIANT

    • Boys affected

    • Girls range from unaffected to mildley affect due to x-inactivation

  • ALWAYS DE NOVO

Clinical Features

  • ***Stimulus-Induced Drop Episodes***

    • collapse when excited or startled

  • Hands

    • Soft, Large, fleshy hand (“puffy”)

    • Short, tapered fingers

  • Dysmorphic facial features

    • Coarsening of facial features

  • Intellectual disability (moderate to severe)



50
New cards

Pitt-Hopkins Syndrome

Gene: TCF4

Inheritance

  • Autosomal Dominant

  • ALWAYS DE NOVO

Clinical Features

  • ****Episodic Hyperventilation/Apena****

    • Rapid breathing (hyperventilation)

    • then followed by breath-holding (apena)

    • Triggered by excitement, anxiety, emotions

  • **Severe Intellectual disability**

  • Absent Speech

  • Severe Constipation


51
New cards

Familial Dysautonomia

Gene: ELP1

Inheritance

  • Autosomal Recessive

  • ***Founder Mutation: Ashkenazi Jewish Ancestry***

    • 1/30 Ashkenazi Jewish Pop. frequency

Clinical Features

  • **Decreased (but not fully absent) Pain sensitivity**

  • Autonomic Dysfunction

    • Unstable blood pressure

    • Unstable body temperature

    • ***Recurrent vomiting episodes***

  • **Absent Tears**

  • Feeding Issues

Diagnostic Criteria also include:

  • Absence of fungiform papillae on the tongue

  • Deep-tendon reflexes


Hallmark: Absent Tears + Autonomic crisis + Insensitivity + Ashkenazi ancestry


DysAUTONOMIA = AUTONOMIC nervous system.

52
New cards

Cockayne Syndrome

Genes: ERCC6 (80%) and ERCC8 (20%) - important for chromosomal breakage repair →

  • Mutations do not cause cancer b/c cells with that much DNA damage APOTOSIS rather than keep dividing

Inheritance

  • Autosomal Recessive

Clinical Features

  • Postnatal growth failure

    • *short stature*

    • low weight

  • ***Microcephaly (Progressive)*** → like RETT; head starts normal than stops growing w/ the body

  • ****Progressive Neurodegeneration****

    • Loss of skills

    • Intellectual disability

    • Ataxia/tremor/spasticity

    • **Hearing Loss**

    • **Vision Loss**

  • ***Photosensitivity***

    • BUT NO INCREASED CANCER RISK


Hallmarks: Photosensitivity+ progressive neurodegeneration+ no cancer predisposition



53
New cards

GLI3-Related Pallister–Hall Syndrome (PHS)

Gene: GLI3 (SHH signaling pathway)

Inheritance

  • Autosomal Dominant

    • 75% Inherited

    • 25% De Novo

  • VARIABLE EXPRESSIVITY

Clinical Features

  • ***Hypothalamic Hamartoma****

    • benign congenital mass of neuron cells

    • can cause:

      • Adrenal+Pituitary insufficiency / endocrine abnormities

      • “laughing” seizures

  • Polydactyl (6 fingers)

  • Epiglottis abnormalities:

    • Bifid Epiglottis

Prognosis

  • HIGHLY VARIABLE: many have nromal lifespan and congtion

  • Longterm outcomes depdne larelgy on

    • encorine dysfunction

    • seizure contro


54
New cards

Sturge-Weber Syndrome

Gene: GNAQ → in the RAS pathway, but not a RASopathy.

  • A neurocutaneous syndrome

Inheritance

  • ****SPORADIC SOMATIC****

    • i.e. Mosaicism

  • Highly variable phenotype

  • NO INHERITANCE

Clinical Features

  • ****Port-Wine Stain Birthmark****

    • towards top of face

    • a “V-1” pattern

  • ***Seizures***

    • start in infancy

  • ***Leptomeningeal Angioma*** (hallmark brain lesion)

  • Glaucoma

  • Range from normal intelligence to severe developmental disability


Hallmark: Port-wine Stain + Leptomeningeal angioma + glaucoma

Stain, Seizures, Somatic Mutation

55
New cards

Cerebral Autosomal Dominant Arteriopathy wit Subcortical Infarct and Leukoencephalopathy (CADASIL)

Gene: NOTCH3 → expressed in vascular smooth muscle

  • Progressive neurodegenerative w strokes IN ADULTHOOD

Inheritance

  • Autosomal Dominant

Clinical Features

An ADULT-ONSET progressive neurodegenerative condition

  • ***Migraine with Aura***: 20s-30s yo

  • ****Recurrent Stroke****: 40-50yo

  • Cognitive Decline:

    • Executive functioning

    • Vascular dementia

***MRI Findings: WHITE MATTER HYPERINTENSITIES***

Treatment/Management

  • No treatments


Hallmark Progression: Migraine w Aura → Recurrent Strokes → Vascular Dementia


56
New cards

Familial Cerebral Cavernous Malformations

Genes: KRIT1(most common), CCM2, PEDCD10 (most severe) → mutations lead to fragile vascular channels that leak/bleed

Inheritance

  • Autosomal Dominant

    • Inherited 90%

    • De Novo 10%

  • ***Incomplete penetrance and variable expressivity*** → within same family vastly different clinical outcomes

    • “Two Hit Theory: inherit one mutation (hit one) + a Somatic mutation arises (hit two) = Cerebral cavernous malformations (CCMs) develop

Clinical Features

  • ****Seizures***

  • **Intracranial Hemorrhage**

    • CCM lesions can bleed easily

  • Epilepsy

  • progressive neurologic deficits

  • Headache

  • MRI FINDINGS: “Popcorn” Cavernous Malformations

Management

  • Highly variable prognosis

    • Some are asymptomatic and unaffected

    • Others are recurrent hemorrhage, epilepsy and neurologic deficits

  • antiseizure medication,

  • surgical resection of lesions


Hallmark: “Caverns look like Popcorns” → Popcorn brain lesions w seizure + hemorrhages


57
New cards

Malignant Hyperthermia

Gene: RYR1 (70%) CACNA1S (less common) → important for calcium regulation in muscles

  • An Pharmacogenetic disorder that causes muscle hypermetabolism

Inheritance

  • Autosomal Dominant

  • low De Novo rate

Clinical Features

Triggered by specific drugs: Volatile Anesthetics or Succinylcholine (Neuromuscular blocker)

  • Muscle Rigidity

  • High CO2 levels

  • ***Hyperthermia***

    • Muscle overactive → leads to quick rise in body temp

  • Rhabdomyolysis

    • elevated CK

Treatment

  • Give Dantrolene

    • Blocks calcium channels → reverse crisis


58
New cards

Inherited Neurodegenerative Diseases

  • Conditions that arise in anatomically normal brains w/ normal function

    • But experience an Earlier than expect and/or MORE SEVERE than expected DECLINE in function

  • Including

    • Alzhimers’s Disease

    • Parkinson’s Disease

    • Amyotrophic Lateral Sclerosis

    • Huntington’s Disease


59
New cards

Most Common Neurodegenerative Diease

Alzheimer’s Disease: also most common irreversible cause of dementia

60
New cards

Alzheimer’s Disease: Risk

Age is a MAJOR risk factor

  • General Population Lifetime risk: 10%

    • slightly higher in women than in men

    • By 65yo - cutoff age for “Early Onset” - 1-3%

    • By 85yo: 20%

    • By 95yo: 45%

  • Familial Alzheimer’s Disease (AD)

    • AD patient’s w/ a (+) fam. history: 10-25%

    • AD Early Onset patient w/ a (+) fam. history: 60%

    • *****Lifetime risk for 1st degree relatives of AD patients: 20-25%*****


61
New cards

Alzheimer’s Disease: Clinical features

  • Progressive impairment of

    • memory

    • judgment

    • decision-making

    • orientation to physical surroundings and language

  • Pathological Hallmarks: need to distinguish from other neurodegenerative disease (BUT NOT USED FOR DIAGONASIS DURING THE LIFETIME →only post mortem (cannot take brain biopsies))

    • Neuronal loss (cortex and hippocampus)

    • Extracellular amyloid plaques

    • Intracellular neurofibrillary tangles

  • NO PROVEN TREATMENTS: But MIND Diet can reduce risk 30-50% over 10 years


62
New cards

Alzheimer’s Disease: Early Onset

Genes: APP, PSEN1, PSEN2

  • Amyloid Protein Production (APP) and Splicing (PSEN1, PSEN2)

  • Abnormal Amyloid protein ‘version’ AB:1-42 is what causes AD

Inheritance

  • Autosomal Dominant

  • HIGHLY penetrant (PS1 in particular)

  • Only 5% of Alzheimer’s Disease

Clinical Features

  • Onset of Alzheimer’s is Before 65yo

    • PSEN1 mutation: Age of onset *28*-62yo



63
New cards

Alzheimer’s Disease: Late Onset

Genes: ApoE; 3 ‘isoforms’ (Alleles) - E2, E3, E4

  • Shuttle LDL through the bloodstream

  • E2 - Reduces risk of AD

  • E3 - No increased risk of AD

  • ****E4 - Increases risk of AD****

Inheritance

  • Autosomal Dominant

Clinical Features

Risk for Late Onset AD depends on how many copies of the APOE alleles

  • APOE4:

    • No E4 Alleles: 10% risk

    • 1 E4 Allele: 20% risk

    • 2 E4 Allele: 25-35% risk

    • Each E4 allele shifts age of onset 5-10 years earlier

  • APOE2

    • Alleles REDUCE risk (but unknown numbers)


64
New cards

Alzheimer’s Disease: Early Onset - Genetic Testing

Who should be tested for Early Onset AD genes?

  • Individuals with Early Onset AD (duh)

  • Individuals with a strong Fam Hx of either: early onset AD OR a clear pattern of Autosomal Dominant Alzheimer disease (vertical transmission, even if it is Late Onset)

    • caution for presymptomatic testing:

      • No proven preventive treatments

      • But, can allow for clinical trial participation or future treatments



65
New cards

Alizhmeris Disease: APOE4 Allele Genotyping

  • ***APOE4 sequencing is NOT DIAGONSTIC*** → despite high association with AD, E4 does not guarantee AD

  • Not sensitivity or predictive for late onset AD

    • Low Negative predictive value for AD: >50% of AD patient has no E4 allele

      • So testing negative for E4 doesn’t mean you're not going to develop AD

    • Incomplete PPV for AD: most people with 1 E4 allele do not develop AD

    • Unclear clinical benefit to knowing ApoE status: knowing may not improve outcome and may cause psychological stress


66
New cards

Alizhimer’s Disease: Potential Preventive+Treatment Strategies

  • Potential:

    • Amyloid “vaccine”

    • Tau inhibitors

    • Statins (lipid lowering)

    • ****The MIND DIET*** (Mediterranean based diet)

      • 50% risk reduction over 10 years

      • 35% risk reduction over 10 years w/ even moderate adherence

  • Treatments

    • Acetylcholenesterase inhibitor: temporarily improve memory but not progression

    • Amyloid Target therapies: Amyloid antibodies + amyloid plaque removers


67
New cards

Parkinson’s Diesases: Basic info

  • 2nd most common Neurodegenerative Disorder

  • 1st most common Neurodegenerative MOVEMENT Disorder

Lifetime Risk

1.5%

Age of Onset

  • Average: 40-70yo

  • Juvenile Onset (JO): less than 20yo

  • Early Onset (EO): 20-40yo

  • Adult Onset (AO): over 40yo

Median Survival

  • 10-15 years from diagnosis


68
New cards

Parkinson’s Disease: Overview

Genes: Many genes w different inheritance - progressive loss of DOPAaminergic neurons

  • LRRK2 (most common for AO), SNCA (rare but penetrant, EO)

  • PARK2 (most common for JO), PINK1 (EO), PARK7 (EO)

Inheritance

  • Autosomal Dominant: LRRK2, SNCA

  • Autosomal Recessive: PARK2, PINK1, PARK7

    • 10% Inherited Parkinsons disease

    • 90% Sporadic Parkinsons disease

Clinical Features

  • Bradykinesia: slowing of movement

  • Resting Tremor:

  • Rigidity

  • Gait Ataxia

  • Minor features:

    • Constipation, Cognitive impairment, dementia, depression, Micrographia (small handwriting)

Pathology

  • Presence of Lewy Bodies → BUT, not unique to Parkison’s

  • Loss of DOPAmingeic neurons

Diagnosis

MADE CLINICALLY NOT VIA GENETIC TESTING

Treatment

  • Primarily dopamine replacement → L-DOPA



69
New cards

Overlap of Parkinson and Other Diease

  • 1st Degree

    • Lewy Body Dementia

    • Alzheimer’s Disease

    • Wilsons disease

    • Dopa-responsive dystonia

  • 2nd Degree

    • Drug induced

    • Toxic exposures

    • Dementia Pugilistica


70
New cards

Parkinson’s Disease: Genes and who to Test

  • PARKIN: Juvenile Onset (<20yo) - Very slow progression,

    • Recessive

    • No Lewy bodies

    • No Dementia

    • 80-90% of JO Parkinson

    • 10-50% of EO Parkinson

  • SNCA: Early onset (20-40yo) - Typical progression,

    • Dominant

    • YES Lewey Bodies

    • Yes Dementia (sometimes)

  • LRRK2: Adult onset (>40yo) - typical progression

    • Dominant

    • NO Lewey bodies

    • No dementia

    • *****INCOMPLETE PENETRANCE: only 30% w/ LRRK2 mutation develop Parkinson*****

    • Good DOPA response

    • ****FOUNDER MUTATIONS: Higher rates of mutation in Ashkenazi + North Africa****


71
New cards

Huntington Disease: Overview

Gene: HTT (protein important for neuron health)

  • CAG repeats create a long glutamine tract in the HTT protein→ causes gain-of-function activity which leads to neuronal dysfunction

    • Normal function: <26 repeats

    • Intermediate: 27-35 repeats → normal function, but risk for expansion - “Anticipation Zone”

    • Reduced Penetrance: 36-39 repeats

    • Complete Penetrance, Pathogenic: >40 repeats

    • Juvenile: >60 repeats

Inheritance

  • Autosomal Dominant

  • Variable Penetrance

  • Anticipation can occur:

    • ESPECIALLY DURING SPERMOGENESIS → Paternal Transmission VERY COMMON

Clinical Features

Average age of onset 35-44yo; Progression over 10years; Death 15-20 yrs after symptom onset

  • Chorea: involuntary movement (“dance-like”)

  • Mood/Personality changes: depression, irritability, OCD

  • Cognitive decline: executive dysfunction, slowed processing, dementia

Juvenile form: 5-10% of HD, Onset before 20yo

  • Also includes: Rigidity, Seizures, Developmental Regression

Treatment

  • currently NO TREATMENTS to alter the course of the disease


72
New cards

Huntington’s Disease: Genetic Testing

HD can be highly penetrant for >40 CAG repeat - very specific Genetic testing protocol is recommended for Asymptomatic at-risk adults

  • Active Psychiatric problems must be stabilized before testing

  • Local counselor should be identified

  • Support person who is NOT at risk for HD should accompany patient

  • Testing Minors for Adult-Onset Huntington Disease is not generally recommended UNLESS there is a direct medical benefit (i.e. patient has Juvenile onset symptoms)

Testing Process

  1. Initial Telephone contact: inform patient of process

  2. Visit #1: Genetic Counseling, Informed consent

  • Mental Health assessment during session: make sure they can handle it

  1. Visit #2: Disclose results, arrange follow-up

  2. Follow up



73
New cards

Spinocerebellar Ataxias

  • Dozens of types

    • All are Trinucleotide Repeat Disorders

    • All are Autosomal Dominant (+FamHx)

  • Present with various degrees of difficulty with:

    • Gait

    • Balance

    • Speech

    • Fine motor skills



74
New cards

Friedreich’s Ataxia

Gene: FXN (important Mitochondrial gene → mitochondrial disease profile: cardiomyopathy, impacts on brain)

  • GAA repeats cause protein dysfunction

  • Normal: <33 Repeats

  • Premutation: 34-65 repeats

  • Reduced Penetrance: 44-66 repeats

  • Pathogenic: >66 repeats

Inheritance

  • Autosomal Recessive

  • 96% w/ symptoms: two FXN copies with ‘disease repeats’

  • 4% w/ symptoms: one allele has normal repats but a pathogenic variant → NEED TO DO DEL/DUP ANAYLSIS

Clinical Features

Age of onset 5-15yo

  • Ataxia: especially limb movement (Falls)

  • ****Absent Ankle Reflexes***** (Feet)

  • Hypertrophic cardiomyopathy (Heart)

  • Diabetes (Sugar)

  • Skeletal finding

    • PES CAVUS

    • Scoliosis


“Fred is FXN to have Feet Falls and Sugar Heart.”



75
New cards

Amyotrophic Lateral Sclerosis (ALS)

Gene: only 10% inherited (familial) while 90% sporadic (simplex)

  • C9orf72 (Most common) 30-40% of FALS: a repeat expansion w/ ***frontotemporal dementia***

  • SOD1: 15-20% of FALS

  • FUS: 3-5% of FALS: younger onset and more aggressive

  • TARDBP: 2-5% of FALS

Inheritance

  • Autosomal Dominant

    • SOD1 can be autosomal recessive

Clinical Features

Age of onset 40-60yo

  • ****NORMAL SENSATIONS****

    • motor neurons affects NOT sensory neurons

  • Lower Neuron degeneration

    • Muscle weakness

    • Muscle wasting

    • Decreased reflexes

  • Upper neuron degeneration

    • Hyperflexia (reflexes respond too strongly)

    • Spasticity

    • Babinksi sign (abnormal reflex of big toe)

  • *****Frontotemporal Dementia***** (not all genes)

    • ALS historically thought to not affect cognition, but some genes overlap with FTD

Treatment

  • historically supportive, but now there are diease slowing drugs


76
New cards

Myopathy

  • Any disease of muscle and can present with:

    • Muscle weakness

    • Muscle Pain

    • Low muscle tone (hypotonia)

  • Can be congenital (at birth) or later in life

  • Skeletal muscle affected → diminished strength, inflammation and muscle loss

    • Proximal muscles (Large muscle groups that attach to the trunk - shoulders, back, hips) more affected than Distal muscles (lower arms, hands, legs, feet) - hard to stand or raise muscle over head

  • Often Cardiac Muscle affect → CARDIOMYOPATHY



77
New cards

Myopathy: Suggestive Tests

  • Serum CPK and/or Aldolase: usually within the muscle, but when muscle is destroyed it is release

    • non-specific for congenital myopathies

  • Electromyography (EMG)/Nerve Conduction Velocity(NCV)

    • “myopathic” Pattern, NCV normal

  • Muscle Biopsy

    • show destroyed muscle cells

    • indicate missing muscle protein


78
New cards

Neuropathy

  • Disorder of peripheral nerves and also present with

    • Weakness

    • Pain (more pins and needles and shooting pain than deep muscle pain)

    • Sensation: decreased or hyperactive

  • Depends on Nerves Affected:

    • Motor Nerves: Decreased strength w/ Pain

      • usually the DISTAL (like hands and feet) muscle rather than proximal (myopathy)

    • Sensory Nerves: Decreased Sensation, Paresthesia

    • Autonomic Nerves: Multisystem involuntary dysfunctions

      • Cardiac: Intolerance of standing/changing position → palpations + passing out

      • GI: Slowed movement of bowels → constipation

      • Skin: Sweat/Temperature dysregualtion


79
New cards

Neuropathy Suggestive Tests

  • Electromyography(EMG)/Nerve Conduction Velocity (NCV)

    • “Neuropathic” slowing of NCV

  • Sudoscan (Low Voltage Sweat Gland Activation)

    • Abnormal with small fiber and autonomic neuropathies

  • Nerve Biopsy


80
New cards

Congenital Hypotonia

  • Low tone in babies: “Floppy” Newborn

  • Tone= the involuntary positioning in the body

  • strength = involuntary muscle activity


81
New cards

Prader-Willi Syndrome

  • Profound Hypotonia: MAGEL2 gene associated

  • the 5 H’s

    • hypotonia

    • Hyperphagia

    • Hypomania

    • Hypopigmentation

    • Hypogonadism

  • Chromosome 15q11-13 microdeletion or paternal methylation defect


82
New cards

Myotonic Dystrophy 1

Gene: DMPK (a protein expressed in muscles)

  • “CTG" repeats in the untranslated region of DMPK gene → create RNA that disrupts a large number of other genes (THE RNA IS “TOXIC” not the DMPK PROTIEN)

    • Normal: <35 repeats

    • Premutation: 35-49 repeats

    • Mild: 50-150 repeats

    • Classic: 100-1000 repeats

    • Congenital: >1000 repeats

Inheritance

  • Autosomal Dominant

  • Passed on more through ***MATERNAL TRANSIMSSION***

    • ***Maternal meiosis more susceptible to EXPANSION***

Clinical Features

  • Mild Form: Adult Onset: 20-70yo

    • Mild Myotonia (unable to release, unclench fist)

    • Cataracts

  • Classical Form: Adult/childhood Onset : 10-30yo

    • Myotonia

    • Muscle Weakness

      • Distal muscles first: hand weakness, foot drop, facial weakness

      • Then proximal weakness

    • Cataracts

    • Cardiac Arrythmia

    • Diabetes

    • **Baldness**

  • ****Congenital Form: ONLY COMES FROM MOTHER (but mother doesn’t need to affected: ANTCIPATION IS VERY STRONG)***

    • Present at Birth w/ Early death

      • Profound congenital hypotonia

      • Respiratory deficits

      • Intellectual disability

      • Reflexes are intact

Treatments

Multiple in clincial trials


83
New cards

Muscular Dystrophies

  • Highly heterogenous

  • But some are simple and monogenic like Duchenne/Becker Muscular dystrophy


84
New cards

Duchenne/Becker Muscular Dystrophies: Overview

Gene: DMD (codes for dystrophin, a structural protein important for muscle fiber contraction)

  • Exon Deletions (60-70%) - ***ALWAYS START WITH DEL/DUP ANALYSIS***

  • Duplication (10%)

  • Sequence variants (20-30%)

Inheritance

  • X-Linked Recessive

  • 2/3 Inherited (from carrier mother)

  • 1/3 Sporadic

Clinical Features

  • Duchene: disruption occurs OUT of reading frame/ is LARGER → fully nonfunctional protein → SEVERE w EARLIER ONSET

  • Becker: Disruption occurs IN frame / smaller deletion → partially functional protein → Less Severe with later onset


85
New cards

Duchenne Muscular Dystrophy - Clinical presentation

Age of Onset 3-5 years old

  • Proximal Muscle Weakness

    • Gower Maneuver: using arms to stand up

    • Wheelchair dependent in 2nd decade

    • Death by 3rd decade - Respiratory or cardiac failure

  • ***Dilated Cardiomyopathy***

  • ****Calf pseudohypertrophy****: enlargement of calves due to fibrofatty replacement of muscle

  • Cognitive Affect: Learning disabilities, ADHD, Autism


Tests

  • Elevated CK Levels (10-100x normal) and Adolase levels

  • ****Absent/extremely low DYSTROPHIN on muscle biopsy***

    • Female carriers are asymptomatic but might develop: Cardiomyopathy, mild weakness, elevated CK


86
New cards

Becker Muscular Dystrophy - Clinical Presentation

Age of onset variable but later than Duchenne (<16yo, 20s, Adulthood) - Death in mid40s yo

  • Slower Progression

  • Preserved ambulation much longer → ***but still lost eventually***

  • Variable weakness

  • ****DIALTED CARDIOMYOPATHY CAN STILL BE SEVERE****

  • ***Calf Pseudohypertrophy Present***

    • MAJOR DIFERENCE FROM DMD: Preservation of the NECK FLEXOR MUSCLE

Tests

  • Elevated CK and Aldolase, but not as much as Duchenne

  • ****Dystrophin Protein present on Muscle Biopsy****


87
New cards

Duchenne/Becker Dystrophy Management

Monitoring

  • Cardiac

    • Female DMD carriers are still at risk for DCM

  • Respiratory

  • Overall Strength

Supportive

  • Physical Therapy

  • Cardio/respiratory support (vent/trach)

Treatment/Preventative

  • cortical steroids - Give in early childhood slow progress of diease

  • Variant specific medications →

    • NBS for DMD/BMD efficacy being studied: early drug interventions show promise to slow progression of diease


88
New cards

Facioscapulohumeral Muscular Dystrophy (FSHD): Overview

Gene: DUX4 (an embryonic development gene that should be OFF in adults), SMCHD1 (epigenetic regulator of DUX4)

  • DELETION of D4Z4 repeats on chr. 4q35 → DUX4 ON (95%)

    • normal: 11-100 D4Z4 repeats

    • FSDH: 1-10 D4Z4 repeats

  • SMCHD1 pathogenic variant = no methylation of D4Z4 region → DUX4 On (5%)

Inheritance

  • Autosomal Dominant

    • 2/3 Inherited

    • 1/3 De Novo

Clinical Features

Age of onset early 20s, SLOW head-to-toe PROGRESSION, ***Asymmetric*** → NORMAL LIFE EXPECTANCY

  • Facial muscles

  • Shoulder + upper arm muscles

  • Lower extremities mainly foot dorsiflexors

    • 20% of patients: Hip + Abdominal muscle → leads to loss of ambulation

  • REFLEXES PRESERVED

  • Other features:

    • Sensio-neural Hearing loss (60%)

    • Atrial Arrythmia

    • Mild Creatine Kinase elevation


89
New cards

Spinocerebellar Ataxia (SCA)

Gene: ATXN1, ATXN7

  • “CAG” repeats in AXTN genes = toxic gain-of-function activity

    • Normal </= 35 CAG repeats

    • Reduced penetrance (RARE) 36-38 CAG repeats

    • Full Penetrance >/= 39 CAG repeats

Inheritance

  • Autosomal Dominant

  • ****Paternal Transmission DRAMATICALLY increased Anticipation****

    • Especially for ATXN7

    • Can result in parent having an SEVERLY affect child: childhood onset, sever diease, rapid progression

Clinical Features

Age of Onset 30-40, Progressive, Life shortening ( 15-25 years after symptom onset)

  • Cerebellar Ataxia

    • Gait Instability

    • Poor hand-eye coordination, eye movements

    • Slurred Speech

  • ****FOR ATXN7 ONLY: Retinal Degeneration******

Genetic Testing



90
New cards

Spinal Muscular Atrophy (SMA)

Gene: SMN1 (important for spinal cord neurons)

  • Deletion of exon 7 of SMN1 in BOTH COPIES = loss of function (95%)

  • Deletion in one SMN1 copy + sequence variant on the other = loss-of function (5%)

  • ***SMN2**** gene: disease modifier → more copies = more SMN protein = MILDER DIEASE

Inheritance

  • Autosomal Recessive

    • ****1:50 carrier frequency****

Clinical Features

Variable onset: SMN2 copies modify - prenatal to adulthood

  • Hypotonia

  • Progressive Skeletal and Respiratory muscle weakness

  • ****Absent Reflexes****

  • Normal Sensation

  • Normal intelligence

Treatment

  • Early treatment crucial: before symptoms develop → IDENTIFED VIA NBS

  • Drugs prevent loss of exon 7 in SMN1 = preserved function

  • Normal milestones and life expectancy


91
New cards

Hereditary Neuropathy



92
New cards

Charcot-Marie tooth (CMT) type 1A

Gene: PMP22 (stabilizes myelin + maintains peripheral nerve function)

  • 1.4 MB DUPLICATION → extra copy of PMP22 = slowed nerve conduction

    • ****START WITH DEL/DUP ANALYSIS****

Inheritance

  • Autosomal Dominant

    • 90% Inherited

    • 10% De Novo

Clinical Features

Average age of onset 10-20yo, slowly progressive start with FEET+LOWER LEGS

  • Neuropathic Pain

  • Distal muscle atrophy (legs)

    • Weakness in Hands + Feet

    • *INVERTED WINE BOTTLE LEGS*

  • *****PES CAVUS***** (high arched feet)

  • Absent reflexes

  • Loss of Sensation

  • Normal Life expectancy

Testing


93
New cards

Hereditary neuropathy with liability to pressure palsies (HNPP)

PMP22 (stabilizes myelin + maintains peripheral nerve function)

  • 1.4 MB DELETION→ loss of a copy of PMP22 = slowed nerve conduction [SAME REGION AS Charcot-Marie tooth]

    • ****START WITH DEL/DUP ANALYSIS***

  • Pressure that normal people could easily tolerate causes NERVE DAMAGE in HNPP patients

Inheritance

  • Autosomal Dominant

    • 80% inherited

    • 20% De Novo

Clinical Features

Age of onset teen to 20syo, Normal Lifespan

  • Recurrent Focal Neuropathies (weakness, numbness and pain from nerve damage)

    • Foot (causes FOOT DROP) → crossing legs, squatting, kneeling

    • Elbow

    • Wrist → Carpal Tunnel syndrome

  • Cognition Normal



94
New cards

Emery–Dreifuss Muscular Dystrophy (EDMD)

Gene: EMD, LMNA (important for muscle cell ability to take mechanical stress)

Inheritance

  • Variable

    • X-Linked : EMD

    • Autosomal Dominant: LMNA

Clinical Features

Age of onset 10yo, Normal cognition

  • ****Contractures****: inability to STRAIGHTEN a joint

    • Elbow*

    • Neck

    • Heels*

  • Muscle Weakness (progressive, after contracture)

    • Shoulders

    • Upper Arms

    • Calves

  • ****Cardiomyopathy****

    • Conduction defects

    • May cause FAINTING

    • Sudden cardiac death a risk

  • Normal Creatine Kinase level


95
New cards

Limb-Girdle Muscular Dystrophy (LGMD)

Gene: 30 genes; Many forms

Inheritance

  • Type 1: Autosomal Dominant

  • Type 2: Autosomal Recessive

Clinical Features

Onset variable: childhood to adulthood; Progressive, ***Symmetrical***

  • Limb-Girdle muscle weakness- proximal muscles around hips and shoulder

    • Pelvic girdle: hips, butt, thighs

    • Shoulder girdle: shoulders, upper arms

    • ****Creates “Waddling Gait”****

  • Cardiomyopathy: depending on the form

  • Sensation Normal

  • Cognition Normal

  • ***Elevated Creatine Kinase***


96
New cards

Trinucleotide Repeat Disorders

  • Huntingtons Diease (CAG)

  • Spinocerebellar ataxia (CAG)

  • Friedreich’s ataxia (GAA)

  • Fragile X Syndrome (CGG)

  • Myoyonic dystrophy (CTG)